Clinical Research Directory

Inclusion Criteria: * Be adult women \>/= 18 years of age. * Be able to read, write, and speak English * Able to give informed consent * Have a history of stage I, II, or III breast cancer * Have a documented visit with an oncologist during the previous 12-months * Have no current evidence of disease * Have persistent pain (unrelated to aromatase inhibitors or chemotherapy-induced peripheral neuropathy) for at least 3 months following treatment for breast cancer * Have pain severity (arithmetic mean of four pain severity items) \>= 2 on Brief Pain Inventory (BPI) * Have worst pain \>= to 4 (0-10 numeric rating scale \[NRS\]) in the preceding week * Be willing and able to adhere to all study-related procedures * Have completed all cancer treatment (including surgery, chemotherapy and/or radiation) at least 4 months prior to enrollment * Have documented lab work with absolute neutrophil count (ANC) \>= 1.0 K/uL and platelets \>= 50 K/uL in the past 12 months * If applicable, maintain self-management of lymphedema symptoms being performed at home at time of study entry Exclusion Criteria: * Metastatic breast cancer (stage IV) * Known bleeding disorder per patient reported history * Cardiac pacemaker or other implanted electronic devices * New or planned new lymphedema treatment during the study period * Currently receiving or ever received acupuncture for present pain condition * Received acupuncture with electrical stimulation for any condition * Received acupuncture for any condition in the past year